Access cutting-edge sarcoma treatment through this clinical trial at a research site in Iowa City. Study-provided care at no cost to qualified participants.
Access sarcoma specialists in Iowa City at no cost
This study follows strict safety protocols and ethical guidelines
All study-related sarcoma treatment provided free
This is a single-arm, phase II study that will enroll a total of 45 subjects. All subjects will have a confirmed diagnosis of metastatic or unresectable soft tissue sarcoma or bone sarcoma. All subjects must have intact Rb, identified at the time of screening, by immunohistochemistry testing of submitted tumor specimen. Subjects will receive Abemaciclib 200 mg twice daily until progression or discontinuation criteria are met.
Sponsor: Medical College of Wisconsin
Check if you qualify for this sarcoma clinical trial in Iowa City, IA
If you're searching for sarcoma treatment options in Iowa City, IA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Iowa City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced sarcoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.